Integrated PET/MRI for patients with colorectal cancer can help physicians decide on appropriate treatment options.
Use of integrated whole-body PET/MRI may aid in the selection of treatment strategies for patients with colorectal cancer, according to a study published in the American Journal of Roentgenology.
Researchers from Korea sought to determine if adding PET and MRI would add clinical value compared with the conventional contrast-enhanced multidetector computed tomography (CECT) alone when evaluating patients with colorectal cancer.
Fifty-one patients with colorectal cancer underwent 18F-FDG PET/MRI and CECT within a 90-day interval between October 2012 and August 2013. The probability of malignancy was assessed on a 5-point scale, and two reviewers in consensus performed evaluations regarding the value, if any, added by PET/MRI to CECT for lesion detection, characterization, and treatment strategy recommendations. Lesions were examined through histopathological findings and imaging, with follow-up. When pulmonary metastatic nodules were detected by chest CT scan, they were evaluated by two reviewers using PET/MRI.[[{"type":"media","view_mode":"media_crop","fid":"44895","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_3123181460550","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"5063","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 128px; width: 171px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"©Spectral-Design/Shutterstock.com","typeof":"foaf:Image"}}]]
The results showed that PET/MRI did add value to CECT for 14 of 51 patients (27.5%). Twelve of these patients (23.5%) had better characterization and two of the 51 (3.9%) had additional detection of extracolonic lesions. This resulted in 11 of the 51 patients (21.6%) experiencing a change in treatment strategy. The authors noted that PET/MRI was significantly superior to CT in depicting colorectal cancer, and that the rate of detection of pulmonary metastatic nodules with PET/MRI was 52.9% (nine of 17).
Although the value of adding PET/MRI to CECT was limited in relation to detecting small pulmonary metastatic modules, the authors concluded that the imaging did add value in the detection of metastatic lesions and characterization of indeterminate lesions overall, suggesting that PET/MRI may aid in the selection of more appropriate treatment strategies.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
August 3rd 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 3rd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 3rd 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 3rd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
August 3rd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.